US Food and Drug Administration (FDA) has denied Elon Musk’s company Neuralink from starting testing the company’s technology on humans, reports Reuters.
The rejection is due to concerns if the battery system could potentially damage brain tissue, and if the device could be safely removed.
Neuralink is developing an implant that will allow direct communication between the human brain and computers, it has so far only tested the technology on animals.
Since December 2022, Neuralink has been under investigation for allegations of suspected animal cruelty in connection with the experiments.


